Latest News - West Pharmaceutical
Top Corporates Hub
West Pharmaceutical
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
06.08.2026 16:31
LIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.
MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised
06.08.2026 15:41
McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.
Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2
06.08.2026 13:55
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]
Is Stronger Q2 Results, Raised Outlook and Buybacks Altering The Investment Case For West Pharmaceutical Services (WST)?
03.08.2026 05:08
In late July 2026, West Pharmaceutical Services reported second-quarter 2026 results showing higher sales and earnings than a year earlier, raised its full‑year 2026 revenue guidance, and completed US$454.28 million of share repurchases under its February 2026 buyback program. The company also issued third‑quarter revenue guidance, highlighted momentum in higher‑value Proprietary Products for biologics and biosimilars, and affirmed a US$0.22 quarterly dividend. Against this backdrop, we’ll...
West Pharmaceutical Services (WST) Raised Guidance, Is The Upside Already Priced In?
03.08.2026 04:32
West Pharmaceutical Services (WST) has drawn fresh investor attention after reporting second quarter results that exceeded expectations and raising full year revenue and adjusted earnings guidance, supported by demand for biologics and biosimilars related products. See our latest analysis for West Pharmaceutical Services. The share price has been volatile in recent months, with a 13.4% 90 day share price return and 23.4% year to date share price return, but a 6.6% decline over 30 days as...
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call
01.08.2026 14:59
West Pharmaceutical Services posted a solid Q2, with revenue and adjusted earnings per share exceeding Wall Street expectations, while the market response remained muted. Management attributed the outperformance to robust growth in its Proprietary Products, particularly high-value product (HVP) components for biologics and biosimilars. CEO Eric Green highlighted, “Our performance was driven by the execution of our strategy and continued operational excellence initiatives,” pointing to the compan
3 Reasons to Avoid WST and 1 Stock to Buy Instead
01.08.2026 09:15
West Pharmaceutical Services has been on fire lately. In the past six months alone, the company’s stock price has rocketed 43%, reaching $339.52 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
29.07.2026 15:42
GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
29.07.2026 15:03
DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.
Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?
29.07.2026 13:05
TECH heads into fiscal fourth-quarter earnings with revenues expected to remain flat, EPS projected to decline, and its $11.3 billion acquisition deal in focus.
West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan
26.07.2026 05:12
West Pharmaceutical Services (NYSE:WST) has entered new long-term exclusive and non-exclusive distributorship agreements with Daikyo Seiko. West Pharmaceutical will distribute Daikyo products outside Japan, while Daikyo will distribute more West products within Japan. The agreements are structured to run over the next decade, reinforcing the companies' cross-border partnership in drug packaging technologies. West Pharmaceutical Services comes into this new distribution arrangement with...
WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook
24.07.2026 13:21
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.
West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift
24.07.2026 08:08
West Pharmaceutical Services beats Q2 earnings, raises FY guidance, and sees biologics-driven margin gains. Click to read this earnings analysis of WST stock.
West Pharmaceutical Services Q2 Earnings Call Highlights
24.07.2026 03:04
West Pharmaceutical Services (NYSE:WST) raised its full-year 2026 outlook after reporting second-quarter results that topped management’s expectations, supported by strong demand for high-value product components, biologics-related offerings and GLP-1 elastomers. Chief Executive Officer and Board C
West Pharmaceutical Services, Inc. 2026 Q2 - Results - Earnings Call Presentation
24.07.2026 01:00
2026-07-24. The following slide deck was published by West Pharmaceutical Services, Inc.
West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For
22.07.2026 16:30
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results tomorrow before market open. Here’s what to expect.
Cardinal Health Expands Home Care Business With Two Acquisitions
22.07.2026 16:19
CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology reach while targeting first-year EPS accretion.
Revvity to Launch Signals for Startups for Emerging Biotech Companies
22.07.2026 15:04
RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.
West (WST) Stock Looks Pricey With Little Room Above Fair Value
22.07.2026 02:12
West Pharmaceutical Services stock has delivered a 64.7% return over the past year, yet the valuation checks and current pricing suggest it may no longer be an obvious bargain, with the Discounted Cash Flow (DCF) estimate pointing to a level that is roughly in line with where the shares trade today. After such a strong run, investors are weighing solid business developments against signals that the stock screens as expensive on several measures. Over the past 1 year, West Pharmaceutical...